Dr. Nada Abdellatif Fadul, MD

Dr. Fadul practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Fadul's NPI, 1912910423, was assigned on August 14, 2006. Dr. Fadul holds Nebraska license 31077.

Dr. Fadul's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Fadul also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Fadul's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. The medical group on file is UNMC Physicians. Dmand AI also links Dr. Fadul to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fadul practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Fadul's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Fadul's licenses on file in 2 states: Nebraska and North Carolina.

CMS data shows 94 Medicare services from Dr. Fadul across 2 procedure codes in 2024, for 40 Medicare patients. Medicare paid $8,942 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 40 Medicare patients who saw Dr. Fadul in 2024. The largest group is 65 to 74, with 13 patients. 75% of them have high blood pressure, and 65% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fadul's median patient age at 59, with 6% women.

In 2024, Dr. Fadul wrote 133 Medicare Part D claims for 29 patients. 51% of them were for generic drugs. CMS names the drug for 36 of them, across 2 drugs with 11 or more claims each, at $93,109 in total drug cost. In 2023, CMS named 170 claims across 9 drugs.

Dr. Fadul accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 144 general payments to Dr. Fadul from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Gilead Sciences, Inc. paid the most, $27,213.